Omar A. Minai
Intensive Care Medicine | Pulmonary Medicine
261 Medical Park Boulevard
Petersburg, VA 23805
Petersburg, VA 23805
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications
The minimally important difference in the six-minute walk test predicts clinical worsening in pulmonary arterial hypertension.
Journal: Respiratory medicine
Published: July 16, 2024
The impact of ambrisentan and tadalafil upfront combination therapy on cardiac function in scleroderma associated pulmonary arterial hypertension patients: cardiac magnetic resonance feature tracking study.
Journal: Pulmonary circulation
Published: December 19, 2017
Improvement in Right Ventricular Strain with Ambrisentan and Tadalafil Upfront Therapy in Scleroderma-associated Pulmonary Arterial Hypertension.
Journal: American journal of respiratory and critical care medicine
Published: June 30, 2017
Lung or Heart-Lung Transplant in Pulmonary Arterial Hypertension: What Is the Impact of Systemic Sclerosis?
Journal: Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation
Published: May 26, 2017
Impact on survival of warfarin in patients with pulmonary arterial hypertension receiving subcutaneous treprostinil.
Journal: Cardiovascular therapeutics
Published: March 24, 2017
Rationale and study design of MOTION: A phase 4, prospective, single-arm, open-label study to measure outcomes in patients with pulmonary arterial hypertension not on active treatment.
Journal: Respiratory medicine
Published: June 08, 2016
Ambrisentan and Tadalafil Up-front Combination Therapy in Scleroderma-associated Pulmonary Arterial Hypertension.
Journal: American journal of respiratory and critical care medicine
Published: September 12, 2015
Effect of Age on Phenotype and Outcomes in Pulmonary Arterial Hypertension Trials.
Journal: Chest
Published: July 01, 2015
Heart rate recovery and survival in patients undergoing stereotactic body radiotherapy for treatment of early-stage lung cancer.
Journal: Journal of radiosurgery and SBRT
Published: January 01, 2015
Outcomes of β-blocker use in pulmonary arterial hypertension: a propensity-matched analysis.
Journal: The European respiratory journal
Published: November 21, 2014
Heart rate recovery is an important predictor of outcomes in patients with connective tissue disease-associated pulmonary hypertension.
Journal: Pulmonary circulation
Published: August 21, 2014
Last Updated: 09/26/2026